Bilibili Inc vs BIO-TECHNE Corp — how do they compare? Bilibili Inc trades at $17.9 (market cap $7.27B), while BIO-TECHNE Corp trades at $71.23 (market cap $11.12B). The key difference: BIO-TECHNE Corp is the larger of the two by market cap, and BIO-TECHNE Corp pays a 0.45% dividend while Bilibili Inc pays none. Which is the better fit depends on your goals.
| BILI | TECH | |
|---|---|---|
Market Cap | $7.27B | $11.12B |
Sector | Media | Health |
52-Week High | $35.92 | $71.38 |
52-Week Low | $15.96 | $43.31 |
Enterprise Value | $5.12B | $11.20B |
Dividend Yield | — | 0.45% |
Trailing returns across standard periods
Bilibili is a leading video sharing and online entertainment platform for Gen Z in China. It offers a diverse range of content, including anime, games, and live broadcasting, fueled by a highly engaged community.
Read more on BILI →Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →